Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Liuzzi A., Chiodini P. G., Botalla L., Cremascoli G., Müller E. E., Silvestrini F. Decreased plasma growth hormone (GH) levels in acromegalics following CB 154(2-Br-alpha ergocryptine) administration. J Clin Endocrinol Metab. 1974 May;38(5):910–912. doi: 10.1210/jcem-38-5-910. [DOI] [PubMed] [Google Scholar]
- Liuzzi A., Chiodini P. G., Botalla L., Silvestrini F., Müller E. E. Growth hormone (GH)-releasing activity of TRH and GH-lowering effect of dopaminergic drugs in acromegaly: homogeneity in the two responses. J Clin Endocrinol Metab. 1974 Nov;39(5):871–876. doi: 10.1210/jcem-39-5-871. [DOI] [PubMed] [Google Scholar]
- Sachdev Y., Gomez-Pan A., Tunbridge W. M., Duns A., Weightman D. R., Hall R., Goolamali S. K. Bromocriptine therapy in acromegaly. Lancet. 1975 Dec 13;2(7946):1164–1168. doi: 10.1016/s0140-6736(75)92655-0. [DOI] [PubMed] [Google Scholar]
- Thorner M. O., Besser G. M. Successful treatment of acromegaly with bromocriptine. Postgrad Med J. 1976;52SUPPL:71–74. [PubMed] [Google Scholar]
- Wass J. A., Thorner M. O., Morris D. V., Rees L. H., Mason A. S., Jones A. E., Besser G. M. Long-term treatment of acromegaly with bromocriptine. Br Med J. 1977 Apr 2;1(6065):875–878. doi: 10.1136/bmj.1.6065.875. [DOI] [PMC free article] [PubMed] [Google Scholar]